Top 5 Stocks to Buy Now
→ Read now. Do not delete. You’ve been warned. (From Porter & Company) (Ad)tc pixel Free OVID Stock Alerts

Ovid Therapeutics (OVID) Institutional Ownership

Ovid Therapeutics logo
$2.32 +0.07 (+3.11%)
Closing price 04:00 PM Eastern
Extended Trading
$2.36 +0.04 (+1.72%)
As of 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Ovid Therapeutics (NASDAQ:OVID)

Current
Institutional Ownership
Percentage
72.24%
Number of
Institutional Buyers
(last 12 months)
40
Total
Institutional Inflows
(last 12 months)
$102.92M
Number of
Institutional Sellers
(last 12 months)
19
Total
Institutional Outflows
(last 12 months)
$11.38M
Get OVID Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ovid Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

OVID Institutional Buying and Selling by Quarter

Ovid Therapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026 Bank of America Corp DE290,432$645K0.0%+49.0%0.220%
5/19/2026 Janus Henderson Group PLC10,714,000$23.73M0.0%N/A8.124%
5/19/2026 Ally Bridge Group NY LLC2,818,459$6.26M5.1%+57.9%2.137%
5/18/2026 ADAR1 Capital Management LLC4,544,113$10.09M0.6%+6.0%3.446%
5/15/2026 OMERS ADMINISTRATION Corp100,100$222K0.0%-20.1%0.076%
5/15/2026 Affinity Asset Advisors LLC10,636,318$23.61M1.2%+48.8%8.065%
5/14/2026 Renaissance Technologies LLC1,104,300$2.45M0.0%-25.6%0.837%
5/14/2026 Sei Investments Co.328,924$730K0.0%N/A0.249%
5/14/2026 Walleye Capital LLC443,362$984K0.0%-16.3%0.336%
5/14/2026 State of Wyoming22,171$49K0.0%N/A0.017%
4/27/2026 Simplify Asset Management Inc.130,813$290K0.0%N/A0.099%
4/20/2026 Assenagon Asset Management S.A.227,742$506K0.0%-63.1%0.173%
4/17/2026 Total Clarity Wealth Management Inc.20,975$47K0.0%-26.7%0.016%
4/17/2026 Sovereign Financial Group Inc.30,000$67K0.0%+200.0%0.023%
2/19/2026 Invesco Ltd.33,308$54K0.0%N/A0.047%
2/18/2026 ADAR1 Capital Management LLC4,285,000$6.99M0.5%+33,256.7%6.017%
2/18/2026 Ikarian Capital LLC247,558$404K0.0%-77.4%0.348%
2/18/2026 Quadrature Capital Ltd87,874$143K0.0%+217.2%0.123%
2/18/2026 Millennium Management LLC1,339,465$2.18M0.0%+35.8%1.881%
2/18/2026 Balyasny Asset Management L.P.325,000$530K0.0%-48.0%0.456%
2/18/2026 Boothbay Fund Management LLC155,741$254K0.0%-68.0%0.219%
2/17/2026 ADAR1 Capital Management LLC4,285,000$6.99M0.5%+33,256.7%6.017%
2/17/2026 Schonfeld Strategic Advisors LLC192,496$314K0.0%-78.2%0.270%
2/17/2026 Ally Bridge Group NY LLC1,785,000$2.91M3.0%N/A2.507%
2/17/2026 RA Capital Management L.P.10,714,000$17.46M0.2%N/A15.046%
2/17/2026 Adage Capital Partners GP L.L.C.3,492,000$5.69M0.0%+158.7%4.904%
2/17/2026 Graham Capital Management L.P.127,459$208K0.0%N/A0.179%
2/16/2026 Squarepoint Ops LLC39,034$64K0.0%-66.0%0.055%
2/16/2026 OMERS ADMINISTRATION Corp125,300$204K0.0%N/A0.176%
2/16/2026 Eventide Asset Management LLC4,285,000$6.99M0.1%N/A6.017%
2/13/2026 Marshall Wace LLP1,271,487$2.07M0.0%+62.3%1.786%
2/13/2026 Walleye Capital LLC530,020$864K0.0%-11.2%0.744%
2/13/2026 Affinity Asset Advisors LLC7,150,000$11.65M0.7%+169.8%10.041%
2/13/2026 AWM Investment Company Inc.899,200$1.47M0.1%N/A1.263%
2/13/2026 State Street Corp276,533$451K0.0%+21.8%0.388%
2/13/2026 Wells Fargo & Company MN720,848$1.18M0.0%-1.4%1.012%
2/12/2026 Jane Street Group LLC883,867$1.44M0.0%+270.7%1.241%
2/12/2026 Renaissance Technologies LLC1,484,478$2.42M0.0%-26.4%2.085%
2/12/2026 Federated Hermes Inc.3,571,000$5.31M0.0%N/A5.015%
2/11/2026 LPL Financial LLC30,000$49K0.0%+150.0%0.042%
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
2/10/2026 Goldman Sachs Group Inc.170,457$278K0.0%+497.7%0.239%
2/9/2026 Geode Capital Management LLC672,004$1.10M0.0%+3.7%0.944%
2/2/2026 Total Clarity Wealth Management Inc.28,600$47K0.0%N/A0.040%
1/12/2026 Benin Management CORP19,000$31K0.0%N/A0.027%
1/9/2026 Assenagon Asset Management S.A.618,019$1.01M0.0%-33.2%0.868%
11/17/2025 Qube Research & Technologies Ltd25,277$33K0.0%-65.3%0.035%
11/17/2025 Parkman Healthcare Partners LLC202,978$264K0.0%N/A0.285%
11/17/2025 Millennium Management LLC986,293$1.28M0.0%-6.3%1.385%
11/17/2025 Integrated Wealth Concepts LLC52,900$69K0.0%N/A0.074%
11/17/2025 Bank of America Corp DE362,707$472K0.0%+2,333.0%0.509%
11/17/2025 Boothbay Fund Management LLC486,877$633K0.0%N/A0.684%
11/14/2025 Schonfeld Strategic Advisors LLC883,154$1.15M0.0%N/A1.240%
11/14/2025 Two Sigma Investments LP341,134$443K0.0%N/A0.480%
11/14/2025 Squarepoint Ops LLC114,923$149K0.0%-48.0%0.162%
11/13/2025 Kennedy Capital Management LLC1,106,638$1.44M0.0%-26.3%1.556%
11/13/2025 Private Advisor Group LLC25,600$33K0.0%N/A0.036%
11/10/2025 Persistent Asset Partners Ltd46,040$60K0.0%N/A0.065%
11/7/2025 GSA Capital Partners LLP265,993$346K0.0%-64.2%0.374%
11/7/2025Vanguard Group Inc.2,820,813$3.67M0.0%+7.0%3.967%
11/4/2025 TLS Advisors LLC18,858$26K0.1%-97.2%0.027%
10/17/2025 Apollon Wealth Management LLC27,500$36K0.0%N/A0.039%
10/7/2025 Assenagon Asset Management S.A.924,576$1.20M0.0%+112.2%1.300%
8/15/2025 Rosalind Advisors Inc.500,000$165K0.1%N/A0.703%
8/15/2025 Rubric Capital Management LP478,533$158K0.0%-91.0%0.673%
8/14/2025 Jane Street Group LLC142,597$47K0.0%N/A0.201%
8/14/2025 Velan Capital Investment Management LP160,000$53K0.1%+64.9%0.225%
8/13/2025 Marshall Wace LLP164,721$54K0.0%N/A0.232%
8/13/2025 Kennedy Capital Management LLC1,502,329$496K0.0%-13.3%2.113%
8/8/2025 Geode Capital Management LLC643,335$212K0.0%-51.7%0.905%
8/1/2025 Y Intercept Hong Kong Ltd160,306$53K0.0%N/A0.225%
7/11/2025 Assenagon Asset Management S.A.435,620$144K0.0%-22.3%0.613%
6/27/2025 Goldman Sachs Group Inc.104,435$33K0.0%-47.3%0.147%
5/21/2025Acadian Asset Management LLC2,088,046$650K0.0%+12.8%2.936%
5/16/2025Goldman Sachs Group Inc.104,435$33K0.0%-47.3%0.147%
5/16/2025Jacobs Levy Equity Management Inc.200,593$63K0.0%-31.2%0.282%
5/16/2025Adage Capital Partners GP L.L.C.1,150,000$359K0.0%+15.0%1.617%
5/14/2025Affinity Asset Advisors LLC667,516$208K0.0%N/A0.939%
5/12/2025Nuveen LLC119,113$37K0.0%N/A0.168%
5/8/2025XTX Topco Ltd93,154$29K0.0%N/A0.131%
4/15/2025Assenagon Asset Management S.A.560,830$175K0.0%+699.9%0.789%
2/17/2025Velan Capital Investment Management LP70,000$65K0.1%N/A0.099%
2/17/2025Madison Avenue Partners LP3,722,627$3.48M0.4%-9.6%5.242%
2/17/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC943,416$881K0.1%+50.2%1.329%
2/17/2025Jacobs Levy Equity Management Inc.291,701$272K0.0%N/A0.411%
2/17/2025Bridgeway Capital Management LLC229,115$214K0.0%-26.0%0.323%
2/17/2025Bank of America Corp DE56,733$53K0.0%+49.7%0.080%
2/17/2025BNP Paribas Financial Markets104,712$98K0.0%-52.5%0.147%
2/14/2025Adage Capital Partners GP L.L.C.1,000,000$934K0.0%N/A1.408%
2/13/2025Kennedy Capital Management LLC1,545,387$1.44M0.0%+1.1%2.176%
2/13/2025Renaissance Technologies LLC107,700$101K0.0%+142.0%0.152%
Why this tiny stock may move before the SpaceX IPO drops (Ad)

The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillion in stored capital will be looking for a home when it does. But the real opportunity isn't the IPO itself. Jovine has identified a small-cap supplier trading near $4 that sits directly in the path of xAI's Colossus infrastructure buildout - and a specific trigger in the S-1 could reprice it overnight.tc pixel

Get the ticker and full briefing before the June roadshow begins
2/13/2025ADAR1 Capital Management LLC130,532$122K0.0%+245.8%0.184%
2/12/2025TLS Advisors LLC680,967$636K1.5%-11.7%0.959%
2/12/2025Takeda Pharmaceutical Co. Ltd.7,531,996$7.01M26.4%N/A10.607%
2/12/2025JPMorgan Chase & Co.1,418,306$1.32M0.0%-3.1%1.997%
2/10/2025Monimus Capital Management LP138,266$129K0.1%N/A0.195%
1/30/2025Rhumbline Advisers84,078$79K0.0%+22.3%0.118%
1/17/2025SG Americas Securities LLC37,636$35K0.0%+83.9%0.053%
1/14/2025Assenagon Asset Management S.A.70,114$65K0.0%-18.7%0.099%
11/19/2024Barclays PLC84,175$98K0.0%+311.2%0.119%
11/16/2024Geode Capital Management LLC1,317,330$1.56M0.0%+1.1%1.855%


OVID Institutional Ownership - Frequently Asked Questions

During the previous two years, 72 institutional investors and hedge funds held shares of Ovid Therapeutics. The most heavily invested institutionals were Janus Henderson Group PLC ($23.73M), Affinity Asset Advisors LLC ($23.61M), RA Capital Management L.P. ($17.46M), ADAR1 Capital Management LLC ($10.09M), Takeda Pharmaceutical Co. Ltd. ($7.01M), Eventide Asset Management LLC ($6.99M), and Ally Bridge Group NY LLC ($6.26M).Learn more on Ovid Therapeutics' institutional investors.

72.24% of Ovid Therapeutics' stock is owned by institutional investors. Learn more on OVID's institutional investor holdings.

Of the 59 institutional investors that purchased Ovid Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Janus Henderson Group PLC ($10.71M), RA Capital Management L.P. ($10.71M), ADAR1 Capital Management LLC ($8.90M), Affinity Asset Advisors LLC ($8.65M), Takeda Pharmaceutical Co. Ltd. ($7.53M), Eventide Asset Management LLC ($4.29M), and Federated Hermes Inc. ($3.57M).

Institutional investors have bought a total of 58,762,818 shares in the last 24 months. This purchase volume represents approximately $102.92M in transactions.

Of the 19 institutional investors that sold Ovid Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Rubric Capital Management LP ($4.84M), Renaissance Technologies LLC ($913.72K), Ikarian Capital LLC ($848.02K), Assenagon Asset Management S.A. ($822.04K), Schonfeld Strategic Advisors LLC ($690.66K), Geode Capital Management LLC ($687.66K), and TLS Advisors LLC ($662.11K).

Institutional investors have sold a total of 11,780,538 shares in the last 24 months. This volume of shares sold represents approximately $11.38M in transactions.


Related Companies

This page (NASDAQ:OVID) was last updated on 6/23/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel